Darren K McGuire

Darren K McGuire

UNVERIFIED PROFILE

Are you Darren K McGuire?   Register this Author

Register author
Darren K McGuire

Darren K McGuire

Publications by authors named "Darren K McGuire"

Are you Darren K McGuire?   Register this Author

100Publications

2958Reads

21Profile Views

Cardiovascular and renal benefits of dapagliflozin in patients with short and long-standing type 2 diabetes: Analysis from the DECLARE-TIMI 58 trial.

Diabetes Obes Metab 2020 Jul 12;22(7):1122-1131. Epub 2020 Mar 12.

Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, The Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.14011DOI Listing
July 2020

Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial.

Diabetes Care 2020 Jul 9. Epub 2020 Jul 9.

Division of Endocrinology and Metabolism, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc20-0437DOI Listing
July 2020

Use of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Type 2 Diabetes and Cardiovascular Disease: A Review.

JAMA Cardiol 2020 Jun 17. Epub 2020 Jun 17.

Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Vascular Center, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamacardio.2020.1966DOI Listing
June 2020

Contemporary Trends in Prescription of Dipeptidyl Peptidase-4 Inhibitors in the Context of US Food and Drug Administration Warnings of Heart Failure Risk.

Am J Cardiol 2020 May 4;125(10):1577-1581. Epub 2020 Mar 4.

Brigham and Women's Hospital Cardiovascular Division and Heart & Vascular Center, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2020.01.053DOI Listing
May 2020

Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.

Circulation 2020 Apr 27;141(15):1227-1234. Epub 2020 Jan 27.

TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (T.A.Z., M.P.B., R.H.M.F., J.F.K., S.A.M., D.L.B., M.S.S., S.D.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044183DOI Listing
April 2020

Science in a Time of Crisis.

Circulation 2020 Apr 21;141(16):1277-1278. Epub 2020 Mar 21.

Departments of Internal Medicine (Cardiology) (J.A.H., D.K.M., J.A.d.L.), UT Southwestern Medical Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.120.046980DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172554PMC
April 2020

Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study.

Diabetes Care 2020 02 16;43(2):468-475. Epub 2019 Dec 16.

Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Jerusalem, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc19-1476DOI Listing
February 2020

Response to Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298-2306.

Diabetes Care 2020 02;43(2):e26-e27

Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dci19-0059DOI Listing
February 2020

Antihyperglycemic therapies and cardiovascular outcomes in patients with type 2 diabetes mellitus: State of the art and future directions.

Trends Cardiovasc Med 2020 Jan 7. Epub 2020 Jan 7.

Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75930, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tcm.2019.12.010DOI Listing
January 2020

Response by Bergmark et al to Letter Regarding Article, "Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial".

Circulation 2020 01 27;141(4):e57-e58. Epub 2020 Jan 27.

Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (B.A.B., D.L.B., B.M.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044819DOI Listing
January 2020

Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score.

Diabetes Care 2019 12 13;42(12):2298-2306. Epub 2019 Sep 13.

Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2337/dc19-0587DOI Listing
December 2019

Recognized Outstanding Reviewers for in 2019.

Circulation 2019 12 16;140(25):2047. Epub 2019 Dec 16.

University of Texas Southwestern Medical Center, Dallas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044918DOI Listing
December 2019

The Dallas Bed Rest and Training Study: Revisited After 50 Years.

Circulation 2019 10 14;140(16):1293-1295. Epub 2019 Oct 14.

Division of Cardiology, University of Texas Southwestern Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.041046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6814251PMC
October 2019

Long-term follow-up of intensive glycaemic control in type 2 diabetes.

Nat Rev Cardiol 2019 09;16(9):517-518

Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41569-019-0241-yDOI Listing
September 2019

Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial.

Circulation 2019 09 31;140(12):1004-1014. Epub 2019 Jul 31.

Thrombolysis in Myocardial Infarction (TIMI) Study Group (B.A.B., D.L.B., K.I., E.K., Y.G., E.B., B.M.S.), Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.119.040144DOI Listing
September 2019

Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes.

Int J Cardiol 2019 08 30;289:58-62. Epub 2019 Apr 30.

Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijcard.2019.04.085DOI Listing
August 2019

FDA guidance on antihyperglyacemic therapies for type 2 diabetes: One decade later.

Diabetes Obes Metab 2019 05 12;21(5):1073-1078. Epub 2019 Mar 12.

Clinical Development, Therapeutic Area Cardiometabolism, Boehringer Ingelheim, Ingelheim, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13645DOI Listing
May 2019

Age at Diagnosis of Type 2 Diabetes Mellitus and Associations With Cardiovascular and Mortality Risks.

Circulation 2019 05;139(19):2228-2237

Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (Araz Rawshani, A. Rosengren, S.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.037885DOI Listing
May 2019

Relative Prognostic Importance and Optimal Levels of Risk Factors for Mortality and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.

Circulation 2019 04;139(16):1900-1912

Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (A. Rawshani, A. Rawshani, B.E., A. Rosengren, S.G.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.037454DOI Listing
April 2019

Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison.

Diabetes Obes Metab 2019 02 25;21(2):261-266. Epub 2018 Sep 25.

Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, Missouri.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/dom.13511
Publisher Site
http://dx.doi.org/10.1111/dom.13511DOI Listing
February 2019

Heart Failure Epidemiology in Patients With Diabetes Mellitus Without Coronary Heart Disease.

J Card Fail 2019 Feb 10;25(2):78-86. Epub 2018 Nov 10.

Cardiology Division, Stony Brook University, Stony Brook, New York, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cardfail.2018.10.015DOI Listing
February 2019

Probing for Vulnerable Plaque in Patients With Diabetes Mellitus.

Arterioscler Thromb Vasc Biol 2019 02;39(2):124-125

From the Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/ATVBAHA.118.312227
Publisher Site
http://dx.doi.org/10.1161/ATVBAHA.118.312227DOI Listing
February 2019

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.

N Engl J Med 2019 01 10;380(4):347-357. Epub 2018 Nov 10.

From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital (S.D.W., M.P.B., T.A.Z., J.F.K., S.A.M., D.L.B., C.T.R., M.S.S.), and the Cardiology Division, Massachusetts General Hospital (M.G.S.) - both in Boston; the Diabetes Unit, Hadassah Hebrew University Hospital, Jerusalem (I.R., O.M., A.C.); the Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan (E.T.K.); Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.); the Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.); Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom (J.P.H.W.); and AstraZeneca Gothenburg, Mölndal, Sweden (I.A.M.G.-N., M.F., P.A.J., A.-M.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1812389DOI Listing
January 2019

Lorcaserin and Renal Outcomes in Obese and Overweight Patients in the CAMELLIA-TIMI 61 Trial.

Circulation 2019 01;139(3):366-375

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (B.M.S., E.A.B., A.Q., S.A.M., K.I., M.P.B., C.T.R., M.S.S., S.D.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.038341DOI Listing
January 2019

Assessing use of patient-focused pharmacotherapy in glycemic management through the Diabetes Collaborative Registry (DCR).

J Diabetes Complications 2018 Nov 9;32(11):1035-1039. Epub 2018 Aug 9.

Saint Luke's Mid America Heart Institute, Kansas, MO, United States of America; University of Missouri-Kansas City, Kansas, MO, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdiacomp.2018.02.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021208PMC
November 2018

Sex differences in management and outcomes of patients with type 2 diabetes and cardiovascular disease: A report from TECOS.

Diabetes Obes Metab 2018 10 19;20(10):2379-2388. Epub 2018 Jun 19.

Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13377DOI Listing
October 2018

Effects of sodium glucose co-transporter 2 inhibitors on the kidney.

Diab Vasc Dis Res 2018 09 2;15(5):375-386. Epub 2018 Jul 2.

1 Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1479164118783756DOI Listing
September 2018

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.

N Engl J Med 2018 09 26;379(12):1107-1117. Epub 2018 Aug 26.

From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston (E.A.B., S.D.W., J.K., K.I., A.Q., M.P.B., C.T.R., M.S.S., B.M.S.); the Cardiovascular Division, University of Texas Southwestern Medical Center, Dallas (D.K.M.); the Section of Endocrinology, Yale School of Medicine, New Haven, CT (S.E.I.); the Department of Medicine, University of Minnesota, Minneapolis (C.L.F.); the Partners Clinical Research Centre, Nassau, Bahamas (C.B.); the Department of Cardiology, Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland (A.B.); Cardiolink Clinical Trials, Monterrey, Mexico (A.G.-C.); McMaster University, Brampton, ON (M.G.), and the Division of Endocrinology and Metabolism, St. Michael's Hospital, University of Toronto, Toronto (L.A.L.) - both in Canada; MedStar Health Research Institute, Hyattsville, MD (N.J.W.); the Cardiology Department, Auckland City Hospital, Auckland, New Zealand (H.D.W.); Eisai, Woodcliff Lake, NJ (T.P., B.F., W.M., C.P., S.D.); National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Sydney (A.C.K.); and the Translational Research Institute for Metabolism and Diabetes, Florida Hospital and the Sanford-Burnham Institute, Winter Park (S.R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1808721DOI Listing
September 2018

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

N Engl J Med 2018 08;379(7):633-644

From the Department of Molecular and Clinical Medicine, Institute of Medicine (Aidin Rawshani, Araz Rawshani, B.E., A. Rosengren, S.G.), and the Health Metrics Unit, Sahlgrenska Academy (S.F.), University of Gothenburg, and the Swedish National Diabetes Register, Center of Registers in Region (Aidin Rawshani, Araz Rawshani, S.F., B.E., A.-M.S., M.M., S.G.), Gothenburg, and the Department of Public Health and Caring Sciences-Geriatrics, Uppsala University, and the Swedish Medical Products Agency, Uppsala (B.Z.) - all in Sweden; the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (N.S.); and the Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (D.K.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1800256DOI Listing
August 2018

Pathways to Cardiorenal Complications in Type 2 Diabetes Mellitus: A Need to Rethink.

Circulation 2018 07;138(1):7-9

University of Texas Southwestern Medical Center, Dallas (D.K.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.118.035083DOI Listing
July 2018

Should Metformin Remain First-Line Medical Therapy for Patients with Type 2 Diabetes Mellitus and Atherosclerotic Cardiovascular Disease? An Alternative Approach.

Curr Diab Rep 2018 07 14;18(9):64. Epub 2018 Jul 14.

Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390-8830, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11892-018-1035-zDOI Listing
July 2018

DECLARE-TIMI 58: Participants' baseline characteristics.

Diabetes Obes Metab 2018 05 14;20(5):1102-1110. Epub 2018 Feb 14.

TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13217DOI Listing
May 2018

Safety of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant in adults.

Vaccine 2018 05 5;36(19):2604-2611. Epub 2018 Apr 5.

Dynavax Technologies Corporation, 2929 Seventh Street, Suite 100, Berkeley, CA 94710, United States. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0264410X183043
Publisher Site
http://dx.doi.org/10.1016/j.vaccine.2018.03.067DOI Listing
May 2018

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.

N Engl J Med 2017 12 13;377(24):2337-2348. Epub 2017 Sep 13.

From the University of Colorado Denver, Aurora (S.K.G.); the University of California at San Diego, San Diego (R.R.H.); Lexicon Pharmaceuticals, The Woodlands (P.B., D.G.-P., P.L., P.S.), the University of Texas Southwestern Medical Center, Dallas (D.K.M.), and Baylor College of Medicine and Texas Children's Hospital, Houston (J.A.K.) - all in Texas; the Diabetes Research Center, University of North Carolina School of Medicine, Durham (J.B.B.); the University of Leicester and University Hospitals of Leicester NHS Trust, Leicester, United Kingdom (M.J.D.); the University of Sydney, Sydney (G.R.F.); University Campus Bio-Medico of Rome, Rome (P.P.); Vall d'Hebron Research Institute, Barcelona, and CIBERDEM-Instituto de Salud Carlos III, Madrid (R.S.); Diabetes Center Auf der Bult, Hannover Medical School, Hannover, Germany (T.D.); and the University of Southern California, Los Angeles (A.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1708337DOI Listing
December 2017

Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With Sitagliptin.

Hypertension 2017 11 28;70(5):907-914. Epub 2017 Aug 28.

From the Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (A.M.N., D.S.G., Y.L., J.B.G., E.D.P.); Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.); Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada (P.W.A.); Division of Endocrinology, University of North Carolina School of Medicine, Chapel Hill (J.B.B.); Merck Research Laboratories, Merck & Co., Inc., Kenilworth, NJ (S.S.E.); The George Washington University Biostatistics Center, Rockville, MD (J.M.L.); Munich Diabetes Research Institute, Helmholtz Center, Germany (E.S.); Department of Cardiovascular Sciences, University of Leuven, Belgium (F.V.d.W.); and Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Churchill Hospital, United Kingdom (R.R.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.117.09482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638706PMC
November 2017

Major Bleeding in Patients With Diabetes and Atrial Fibrillation Treated With New Oral Anticoagulants-Reply.

JAMA Cardiol 2017 10;2(10):1168

TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://cardiology.jamanetwork.com/article.aspx?doi=10.1001/j
Publisher Site
http://dx.doi.org/10.1001/jamacardio.2017.2034DOI Listing
October 2017

Diabetes medications and cardiovascular outcome trials: Lessons learned.

Cleve Clin J Med 2017 Oct;84(10):759-767

Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3949/ccjm.84gr.17006DOI Listing
October 2017

Longitudinal changes in serum 25-hydroxyvitamin D in the Dallas Heart Study.

Clin Endocrinol (Oxf) 2017 Sep 14;87(3):242-248. Epub 2017 Jun 14.

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cen.13374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561481PMC
September 2017

Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin).

Circulation 2017 Sep 16;136(13):1193-1203. Epub 2017 Jun 16.

From Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (N.J.P., A.M.N., K.S.P., J.B.G., Y.L., E.D.P.); Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, United Kingdom (M.A.B., R.R.H.); Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada (P.W.A.); St. Michael's Hospital, University of Toronto, Ontario, Canada (R.G.J.); Division of Cardiology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas (D.K.M.); Noordwest Ziekenhuisgroep, Department of Cardiology, Alkmaar, the Netherlands (J.C.H.); Department of Cardiology, Oslo University Hospital, and University of Oslo, Norway (S.H.); University of Helsinki and Helsinki University Hospital, Finland (T.E.S.); University of Oulu, Center for Life Course Health Research, Finland (T.E.S.); and Department of Endocrinology and Metabolism, School of Medicine (Kastamonu), Hacettepe University, Ankara, Turkey (T.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.027252DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614823PMC
September 2017

Residual Angina After Elective Percutaneous Coronary Intervention in Patients With Diabetes Mellitus.

Circ Cardiovasc Qual Outcomes 2017 Sep;10(9)

From the Saint Luke's Mid America Heart Institute, Kansas City, MO (A.G., M.K., F.T., P.G.J., J.A.S., J.-S.J., S.V.A.); University of Missouri-Kansas City (A.G., M.K., J.A.S., S.V.A.); Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (D.K.M.); The Queen Elizabeth Hospital Discipline of Medicine, University of Adelaide, Central Adelaide Local Health Network, Australia (J.F.B.); Division of Cardiology, Emory University School of Medicine, Atlanta, GA (A.G.); Massachusetts General Hospital Department of Medicine, Boston, MA (N.M.B.); and Division of Cardiology, Beth Israel Deaconess Medical Center, Boston (R.W.Y.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.117.003553DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611809PMC
September 2017

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

N Engl J Med 2017 08 12;377(8):723-732. Epub 2017 Jun 12.

From the Research Medical Center, Kansas City, MO (S.P.M.); University of Texas Southwestern Medical Center, Dallas (D.K.M.); Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto (B.Z.); Imperial Clinical Trials Unit, Imperial College London, London (N.R.P.); University of Washington, Seattle (S.S.E.); Medical University of Graz, Graz, Austria (T.R.P.); Florida Hospital Translational Research Institute for Metabolism and Diabetes and Sanford Burnham Prebys Medical Discovery Institute, Orlando (R.E.P.); Novo Nordisk, Søborg, Denmark (P.-M.H., M.L., K.B.-F., A.M., S.S., K.K.); and University of North Carolina School of Medicine, Chapel Hill (J.B.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1615692DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731244PMC
August 2017

Dual antiplatelet therapy in patients with diabetes and acute coronary syndromes managed without revascularization.

Am Heart J 2017 Jun 27;188:156-166. Epub 2017 Mar 27.

Duke Clinical Research Institute, Durham, NC, USA; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2017.03.015DOI Listing
June 2017

Multimodality Strategy for Cardiovascular Risk Assessment: Performance in 2 Population-Based Cohorts.

Circulation 2017 05 30;135(22):2119-2132. Epub 2017 Mar 30.

From Departments of Medicine (J.A.d.L., B.L., J.P.B., D.K.M., M.H.D., A.K.) and Clinical Sciences (C.R.A., J.D.B., D.K.M.), University of Texas Southwestern Medical Center, Dallas; Institute for Exercise and Environmental Medicine, Texas Health Presbyterian, Dallas (B.L.); Inova Heart and Vascular Institute, Fall Church, VA (C.R.d.); Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (T.J.W.); Departments of Medicine and Radiological Sciences, Wake Forest Health Sciences, Winston-Salem, NC (W.G.H.); Department of Medicine, University of Maryland School of Medicine, Baltimore (S.L.S.); The Johns Hopkins University School of Medicine, Baltimore, MD (P.O.); Los Angeles Biomedical Research Institute, CA (M.B.); Departments of Preventive Medicine and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (P.G.); and Baylor College of Medicine, Houston, TX (G.M.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.117.027272DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486874PMC
May 2017

Corrections needed to 2016 ESC and AHA guidelines on heart failure.

Lancet Diabetes Endocrinol 2017 05 5;5(5):325-326. Epub 2017 Apr 5.

Diabetes Trials Unit, Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-8587(17)30102-XDOI Listing
May 2017

Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease.

N Engl J Med 2017 05;376(20):1933-1942

From the Cleveland Clinic Coordinating Center for Clinical Research (C5Research), Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland (A.M.L., V.M., E.M., K.W., D.M., S.E.N.); South Australian Heart and Medical Research Institute, University of Adelaide, Adelaide (S.J.N.), and School of Medical Sciences, University of New South Wales, Sydney (P.J.B.) - both in Australia; Eli Lilly, Indianapolis (J.S.R., G.R., B.V., G.W.); Washington Cardiovascular Associates, Medstar Research Institute, Washington, DC (H.B.B.); Centre for Cardiovascular Science, University of Edinburgh, Edinburgh (K.A.A.F.); Beth Israel Deaconess Medical Center, Boston (C.M.G.); Duke University Medical Center, Durham, NC (C.G.); Université Sorbonne Paris 6, ACTION Study Group, Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Institut de Cardiologie, Paris (G.M.); Penn Heart and Vascular Center, Philadelphia (D.R.); Columbia University, New York (A.R.T.), and Saratoga Cardiology Associates, Saratoga Springs (D.K.) - both in New York; St. Michael's Hospital, Toronto (S.G.), Recherche Médicale Saint-Jérôme, Saint-Jérôme, QC (Y.P.), and Centre de Santé et de Services Sociaux du Nord de Lanaudière-Centre Hospitalier Régional de Lanaud, Saint-Charles-Borromée, QC (S.K.) - all in Canada; Instituto Cardiovascular de Buenos Aires, Buenos Aires (D.C.); University of Texas Southwestern Medical Center, Dallas (D.K.M.); Heart Institute (InCor)-University of São Paulo Medical School, São Paulo (J.C.N.); Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosi, Mexico (J.L.L.-P.); the First Affiliated Hospital of Harbin Medical University, Harbin, China (W.L.); and South Oklahoma Heart Research, Oklahoma City (N.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1609581DOI Listing
May 2017

Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes.

N Engl J Med 2017 04;376(15):1407-1418

From the Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg (Aidin Rawshani, Araz Rawshani, B.E., A. Rosengren, S.G.), and the Swedish National Diabetes Register, Center of Registers in Region (Aidin Rawshani, Araz Rawshani, S.F., B.E., A.-M.S., M.M., S.G.), Gothenburg, Sweden; the Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (D.K.M.); and the Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom (N.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1608664DOI Listing
April 2017

Range of Risk Factor Levels: Control, Mortality, and Cardiovascular Outcomes in Type 1 Diabetes Mellitus.

Circulation 2017 Apr 22;135(16):1522-1531. Epub 2017 Feb 22.

From Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (Aidin Rawshani, Araz Rawshani, B.E., A. Rosengren); Swedish National Diabetes Register, Center of Registers in Region, Gothenburg, Sweden (Aidin Rawshani, Araz Rawshani, S.F., B.E., A.-M.S., M.M., S.G.); Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas (D.K.M.); and Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK (N.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025961DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400410PMC
April 2017